Riley Fadden

1.6k citations
19 papers · 918 indexed · 1 hit paper · h-index 8
Topics
Cancer Immunotherapy and Biomarkers (15 papers)Colorectal Cancer Treatments and Studies (5 papers)Melanoma and MAPK Pathways (4 papers)

In The Last Decade

Riley Fadden

18 papers receiving 900 citations

Hit Papers

High‐dose glucocorticoids for the treatment of ipilimumab...20182026202020232018100200300

Peers

Riley Fadden
Comparison fields: 5 of 56
  • Oncology 714
  • Epidemiology 237
  • Neurology 191
  • Immunology 143
  • Endocrinology, Diabetes and Metabolism 110
Replace Anne-Laure Voisin with:
Anne-Laure Voisin France
Guillermo Crespo Spain
Hirotaka Ono Japan
Mikako Warren United States
Won Young Park South Korea
Wafae Iraqi France
Brinda Rao Korivi United States
Kae Kawachi Japan
Jordi Juncà Spain
Antonio Scapinello Italy
Riley Fadden relative to Anne-Laure Voisin France Anne-Laure Voisin's profile →
Citations per field
00.5×10×15.7×
Anne-Laure Voisin · 1×
Citations per year

Countries citing papers authored by Riley Fadden

Since Specialization
Citations

This map shows the geographic impact of Riley Fadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riley Fadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riley Fadden more than expected).

Fields of papers citing papers by Riley Fadden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riley Fadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riley Fadden. The network helps show where Riley Fadden may publish in the future.

Co-authorship network of co-authors of Riley Fadden

This figure shows the co-authorship network connecting the top 25 collaborators of Riley Fadden. A scholar is included among the top collaborators of Riley Fadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riley Fadden. Riley Fadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 3
2 2
3 23
4 3
5 2
6 8
7 24
8 2
9 7
10 10
11 75
12 3
13 2
14
High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanomabreakdown →
348
15 2
16 0
17 2
18 363
19
Large hiatal hernias, anemia, and linear gastric erosion: studies of etiology and medical therapy.
39

About Riley Fadden

Riley Fadden is a scholar working on Oncology, Gastroenterology and Speech and Hearing, having authored 19 papers that have together received 918 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Colorectal Cancer Treatments and Studies (5 papers) and Melanoma and MAPK Pathways (4 papers). The work is most often cited by research in Oncology (714 citations), Neurology (191 citations) and Genetics (85 citations). Riley Fadden has collaborated with scholars based in United States, China and Ethiopia. Frequent co-authors include Ryan J. Sullivan, Donald P. Lawrence, Alexander T. Faje, Lisa B. Nachtigall, Anne Klibanski, Nicholas A. Tritos, Justine V. Cohen, Krista M. Rubin, Keith T. Flaherty and Christine Freedman. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026